{"version":"1.0","type":"link","title":"BRAF-AXL-PD-L1 Signaling Axis as a Possible Biological Marker for RAI Treatment in the Thyroid Cancer ATA Intermediate Risk Category.","author_name":"Pizzimenti C 외","author_url":"https://prs-insight.online/author/Pizzimenti%20C","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/145694","thumbnail_width":1200,"thumbnail_height":630}